Trial intelligence / Profile preview

Tan-Re-Qing Capsule for acute influenza

ChiCTR1800019454Phase 4Not yet recruiting

Sponsor
Beijing Hospital of Traditional Chinese Medicine
Start
Nov 2018
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of tanreqing in influenza (2 arms), sponsored by Beijing Hospital of Traditional Chinese Medicine. Primary endpoint: Median symptom relief time. Planned start Nov 2018; status: not yet recruiting.

02

Drugs

tanreqing
03

Conditions

influenza

Beyond the preview

Go deeper on ChiCTR1800019454.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1800019454.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call